Just not sure about how how the doctor assess the patient conditions to decide if it is necessary to use the product or not. Probably a patient has a good kidney and that deemed 'low risk' so the hospital may or may not use DyeVert? Probably the real low risk patients will have private insurance to cover the longer stay in hospital. But yes you're right, the doctors know what they are doing so I shouldn't worry about it.
- Forums
- ASX - By Stock
- OSP
- Ann: CE Marking received for core European product
Ann: CE Marking received for core European product, page-45
-
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online